Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
Alexander Bagaev, Nikita Kotlov, Krystle Nomie, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 845-865.e7
Open Access | Times Cited: 829

Showing 1-25 of 829 citing articles:

Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
Ruidong Xue, Qiming Zhang, Qi Cao, et al.
Nature (2022) Vol. 612, Iss. 7938, pp. 141-147
Closed Access | Times Cited: 466
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy
Yao Liu, Zhenzhen Xun, Kun Ma, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 4, pp. 770-782
Closed Access | Times Cited: 313
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Ruben Bill, Pratyaksha Wirapati, Marius Messemaker, et al.
Science (2023) Vol. 381, Iss. 6657, pp. 515-524
Open Access | Times Cited: 236
Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
Zhen Zhang, Xiangyang Zeng, Yinghua Wu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 210
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies
Antonio Passaro, Julie R. Brahmer, Scott Antonia, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 6, pp. 598-610
Closed Access | Times Cited: 188
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Carlo Genova, Chiara Dellepiane, Paolo Carrega, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 161
Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
Aiping Zhang, Kai Miao, Heng Sun, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 3019-3033
Open Access | Times Cited: 151
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
Song Li, Wenbin Yu, Fei Xie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 135
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1009-1016
Open Access | Times Cited: 130
Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
Jianxia Li, Cheng Wu, Huabin Hu, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1152-1169.e7
Closed Access | Times Cited: 130
Network-based machine learning approach to predict immunotherapy response in cancer patients
JungHo Kong, Doyeon Ha, Juhun Lee, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 129
Early Tumor–Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer
Ryul Kim, Minae An, Hyuk Lee, et al.
Cancer Discovery (2021) Vol. 12, Iss. 4, pp. 984-1001
Open Access | Times Cited: 121
Discovering dominant tumor immune archetypes in a pan-cancer census
Alexis J. Combes, Bushra Samad, Jessica Tsui, et al.
Cell (2021) Vol. 185, Iss. 1, pp. 184-203.e19
Open Access | Times Cited: 115
The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
Qi Zhang, Rober Abdo, Cristiana Iosef, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 108
Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)
Yunpeng Yang, Jianji Pan, Hui Wang, et al.
Cancer Cell (2023) Vol. 41, Iss. 6, pp. 1061-1072.e4
Open Access | Times Cited: 105
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
Yingcheng Wu, Jiaqiang Ma, Xupeng Yang, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1422-1439.e24
Closed Access | Times Cited: 101
Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment
Chenxi Ma, Chengzhe Yang, Ai Peng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 97
Single-cell profiling of tumour evolution in multiple myeloma — opportunities for precision medicine
Ankit K. Dutta, Jean-Baptiste Alberge, Romanos Sklavenitis‐Pistofidis, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 223-236
Closed Access | Times Cited: 92
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy
Zicheng Zhang, Lu Chen, Jun Chen, et al.
EBioMedicine (2022) Vol. 83, pp. 104207-104207
Open Access | Times Cited: 90
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
Nan Zhang, Hao Zhang, Wantao Wu, et al.
Theranostics (2022) Vol. 12, Iss. 13, pp. 5931-5948
Open Access | Times Cited: 84
Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer
Shaoquan Zheng, Yutian Zou, Yuhui Tang, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 77
Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer
Jie Xia, Zhangjuan Xie, Gengming Niu, et al.
Immunology (2022) Vol. 168, Iss. 1, pp. 135-151
Open Access | Times Cited: 76
Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression
Ruiping Wang, Shumei Song, Jiang‐Jiang Qin, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1407-1426.e9
Open Access | Times Cited: 75
Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
Yan Qin, Yanling Liu, Xiaoyun Xiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 74
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer
Andrew Chow, Fathema Uddin, Michael Liu, et al.
Immunity (2022) Vol. 56, Iss. 1, pp. 93-106.e6
Closed Access | Times Cited: 71
Page 1 - Next Page

Scroll to top